Erin Godecke is a Director of Allied Health Research at Sir Charles Gairdner and Osborne Park Health Care Group and Senior Research Fellow at ECU and received a Charlies Foundation for Research Bright Ideas Grant (2023/24) for her project “Determining dose limiting factors for aphasia intervention in clinical trials.”

Aphasia is an acquired language difficulty that occurs when the areas of the brain that are responsible for language are damaged due to stroke, traumatic brain injury, brain tumor, a type of dementia called Primary Progressive Aphasia, and epilepsy. Affecting approximately 140,000 people in Australia, the condition can cause difficulty in communication areas from speech and language comprehension, difficulty reading, writing, using numbers and using communicative gestures.

In terms of the research around Aphasia, Erin and her team identified a need for a re-structure in how research is better targeted to what patients in early recovery think is important. The original questions that were set to affected patients were based around their experience about having speech sessions in hospital while they were recovering. Early findings showed that the questions were not relevant to people in early recovery stages and the research pivoted to a new focus.

Erin and her team worked with the i-Decide consumer group (people with lived experience of aphasia) to come up with better questions on the topic and are now going back to the drawing board to make the research better targeted to what people in early recovery think is important. This information helped shape many early recovery studies and lead to building this information to all the team’s new research. 

“We are now way better informed and we’ve been able to use what we learned in this project to develop new grants, interpret information on existing grants and work with people with lived experience to plan bigger projects.” Says Erin.

The project’s overarching benefits are that the research is now fully co-designed, solidifying a strong working network with researchers and affected patients with their own lived experience, to help guide future research and early recovery. The progress of this project has also helped staff increase their capacity and knowledge regarding the process of undertaking co-design research, and has allowed the overall project to be submitted to Edith Cowan University to be re-shaped into a PhD or Masters degree for someone to continue the work.

The resulting impact from the Charlies Foundation for Research funding allowed a clinician who had not done research before to be involved in the process in a very supported environment. It meant quarantined time for them to focus on being curious and learning the scientific way to conduct research co-design and to answer qualitative questions and do qualitative research helping to understand the ‘why’ of the scientific question they were asking.

For Erin, the funding helped her to be able to train a new clinician to start research, but it also helped ensure the information was right before putting it into new projects.

Erin stated: “Initially, I wanted to get the project completed and the answers ticked off. I realised pretty quickly that we’d not planned the research (despite this being part of a PhD project) adequately and not used true co-design. This was a big sticking point for the project.

This funding From Charlies Foundation for Research allowed us to redesign the project and take direction from people who we were ultimately trying to help recover. The insights this gave a multifaceted and have had a ripple effect into all other aspects of our clinical practice and research design.”

The team are now working on a large-scale follow-up study to do a ‘nested study’ (study within a study) looking at the effects of early aphasia therapy in long-term recovery and the role that therapy plays in motivation, success and long-term recovery.

This research advances knowledge by strengthening how people with aphasia are meaningfully included in health and rehabilitation research, from study design through to dissemination.